Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.
Borg C, Terme M, Taïeb J, Ménard C, Flament C, Robert C, Maruyama K, Wakasugi H, Angevin E, Thielemans K, Le Cesne A, Chung-Scott V, Lazar V, Tchou I, Crépineau F, Lemoine F, Bernard J, Fletcher JA, Turhan A, Blay JY, Spatz A, Emile JF, Heinrich MC, Mécheri S, Tursz T, Zitvogel L. Borg C, et al. Among authors: taieb j. J Clin Invest. 2004 Aug;114(3):379-88. doi: 10.1172/JCI21102. J Clin Invest. 2004. PMID: 15286804 Free PMC article.
Exosome-based immunotherapy.
Chaput N, Taïeb J, Schartz NE, André F, Angevin E, Zitvogel L. Chaput N, et al. Among authors: taieb j. Cancer Immunol Immunother. 2004 Mar;53(3):234-9. doi: 10.1007/s00262-003-0472-x. Epub 2004 Jan 16. Cancer Immunol Immunother. 2004. PMID: 14727085 Free PMC article. Review.
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection.
Chaput N, Schartz NE, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L. Chaput N, et al. Among authors: taieb j. J Immunol. 2004 Feb 15;172(4):2137-46. doi: 10.4049/jimmunol.172.4.2137. J Immunol. 2004. PMID: 14764679
The potential of exosomes in immunotherapy.
Chaput N, Taïeb J, André F, Zitvogel L. Chaput N, et al. Among authors: taieb j. Expert Opin Biol Ther. 2005 Jun;5(6):737-47. doi: 10.1517/14712598.5.6.737. Expert Opin Biol Ther. 2005. PMID: 15952905 Review.
The potential of exosomes in immunotherapy of cancer.
Chaput N, Taïeb J, Schartz N, Flament C, Novault S, André F, Zitvogel L. Chaput N, et al. Among authors: taieb j. Blood Cells Mol Dis. 2005 Sep-Oct;35(2):111-5. doi: 10.1016/j.bcmd.2005.05.009. Blood Cells Mol Dis. 2005. PMID: 16027014 Review.
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L. Ghiringhelli F, et al. Among authors: taieb j. J Exp Med. 2005 Oct 17;202(8):1075-85. doi: 10.1084/jem.20051511. J Exp Med. 2005. PMID: 16230475 Free PMC article.
601 results